Vincerx Pharma, Inc.
VINC
$0.809
-$0.0102-1.25%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/28/2025
-
GuruFocus
2/28/2025
-
The Fly
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
Seeking Alpha - Healthcare
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
The Fly
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
Globe Newswire
2/28/2025
-
The Fly
2/15/2025
-
GuruFocus
2/12/2025
-
GuruFocus
1/30/2025
-
MarketBeat
1/29/2025
-
TipRanks Financial Blog
1/29/2025
-
The Fly
1/29/2025
-
GuruFocus
1/29/2025
-
Globe Newswire
1/28/2025
-
MarketBeat
1/28/2025
-
TipRanks Financial Blog
1/28/2025
-
The Fly
1/24/2025
-
BizJournals.com - Nat'l Business News
1/24/2025
-
TipRanks Financial Blog
1/24/2025
-
The Fly
1/23/2025
-
GuruFocus
1/23/2025
-
The Fly
1/23/2025
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 800 6676
Address
260 Sheridan Avenue
Palo Alto, CA 94306
Palo Alto, CA 94306
Country
Year Founded
Business Description
Sector
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is...
more
